Teams from IDDO and WWARN are excited to once again be taking part in the European Congress on Tropical Medicine and International Health, ECTMIH.

Researchers have found that severe malnutrition is associated with lower exposure to the antimalarial drug lumefantrine in children treated with artemether-lumefantrine, the most common treatment for uncomplicated falciparum malaria. The study, which is the first to specifically address this, has be...

There’s still time to apply for a National Institute for Health Research, NIHR, Global Health Policy and Systems Research Development Award.

IDDO's WWARN hosted a successful workshop in West Africa aimed at improving researchers’ skills. The aim of the workshops was two-fold; to train researchers in best practice of designing, conducting, analysing and reporting antimalarial drug clinical trials, and also to build expertise within the...

New research published in Open Forum Infectious Diseases has found that a longer follow-up is required to assess antimalarial drug efficacy in pregnant women. This was found across all drugs assessed in low malaria transmission settings. The report’s authors have called for guidelines specifically f...

IDDO’s visceral leishmaniasis (VL) collaboration is working on two new projects looking at the treatment of VL.

WWARN’s extensive scientific work has informed changes in dosage and combinations of antimalarial drugs and has led to policy change. 

IDDO Researchers presented at the European CDISC Interchange held in Amsterdam, Netherlands from May 6 to 7, 2019.

A letter signed by IDDO, members of the Chagas Platform and the Chagas Global Coalition calling on governments, organisations and donors to intensify efforts to control and eliminate Chagas has been presented to the World Health Organization (WHO).

IDDO and WWARN's Clinical Scientific Group have published research in BMC Medical Research Methodology comparing different statistical approaches for deriving cumulative estimates of drug efficacy from clinical studies. Results indicate that the Cumulative Incidence Function (CIF) approach should be...

The Ebola Data Platform, a pioneering collaboration in Ebola and emerging infections, has today appointed nine members for its first Data Access Committee (DAC), overseen and chaired by TDR, the Special Programme for Research and Training in Tropical Diseases, hosted at WHO.

La plateforme de données Ebola, une collaboration pionnière dans le domaine d'Ebola et des infections émergentes, a nommé aujourd'hui neuf membres à son premier Comité d'accès aux données (CAD), supervisé et présidé par le TDR, le Programme spécial de recherche et de formation sur les maladies tropi...

IDDO has published a Draft Research Agenda for open review on visceral leishmaniasis (VL) for feedback and comments from the wider VL research community. The deadline for comments is 5 July 2019.

Professor Joel Tarning, Head of Clinical Pharmacology at MORU, and Head WWARN’s Pharmacometrics Group will present highlights on population PK/PD modelling to assess the dosing of antimalarial drugs in vulnerable groups. Dr Makoto Saito will share highlights from his research on antimalarial treatme...

Research collaboration maps close to 10,000 samples on molecular markers surveyor, in near real-time.

IDDO's Director Philippe Guerin and colleagues have recently published a framework for the reporting and interpretation of clinical microbiology data in BMC Medicine. Read the research.

Malaria is still a global health burden, despite numerous coordinated efforts for eradication. One obstacle to eradication is the malaria parasite’s quick adaptation to anti-malarial drugs resulting in drug resistance. Resistance mechanisms are ill understood for many antimalarials, making it diffic...

A Ki Data Challenge has been launched by Grand Challenges Africa (GCA) - a programme of the African Academy of Sciences (AAS) supported through the AAS funding and programmes implementation platform, the Alliance for Accelerating Excellence in Science in Africa (AESA) - and the African Academy of Sc...

Widely used malaria treatment to prevent malaria in pregnant women at risk of failing in areas where drug resistance is rising.

Rob van der Pluijm presents findings from the Tracking Resistance to Artemesinin Collaboration II programme, which looks at the further extension of drug resistant malaria in Southeast Asia, and the innovative analyses of Triple artemisinin combination therapies (TACTs). Latest news of the launch pl...